Asia Pacific Thyroid Function Tests Devices Market was worth USD xx billion in 2018 and estimated to be growing at a CAGR of xx%, to reach USD xx billion by 2023. The market is showcasing evident potential in the mentioned forecasting period. The market continues to gain momentum with the rapid development in the medical industry.
Thyroid Function Test Devices (TFT) includes a variety of blood tests which are performed to know the functions of thyroid gland. Epidemiological information from WHO states that there exist more than 750 million cases Asia Pacific with thyroid ailments. Many thyroid ailments like Hypothyroidism, Hyperthyroidism, Grave’s Disease, Hashimoto’s Disease, and Thyroiditis can be diagnosed with the TFT. Hyperthyroidism and Hypothyroidism are the main indications of thyroid ailments.
Key factors propelling the growth of the Asia Pacific Thyroid Function Tests Devices market include growing prevalence of thyroid ailments, rising expenditure on healthcare infrastructure and collaborations within pathologists and diagnostic companies along with consumer demand to provide quick decision making. Research suggests that there is urgent need of advanced diagnostics centres, which will enable better and trusted outcomes.
The Asia Pacific Thyroid Function Tests Devices market is segmented on the basis of Disease indication into Type TSH Tests (Thyroid Stimulating Hormone Test), FT4 Tests (Free T4), and FT3 Tests (Free T3). Based on Usage, the market is segmented into Hospitals, Acute Care Centers, Diagnostic Laboratories and Clinics.
Geographically, Asia Pacific is segmented into India, China, Japan and South Korea. Due to the presence of such developing countries, this market is forecasted to show highest growth in the future years.
Some of the major companies in this market are Beckman Coulters, Siemens Healthcare Diagnostics, bioMérieux Inc, DiaSorin S.p.A and IBL-America and Others.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Disease indication
5.1.1 Introduction
5.1.2 Type TSH Tests (Thyroid Stimulating Hormone Test)
5.1.3 FT4 Tests (Free T4)
5.1.4 FT3 Tests (Free T3)
5.1.5 Y-o-Y Growth Analysis, By Disease indication
5.1.6 Market Attractiveness Analysis, By Disease indication
5.1.7 Market Share Analysis, By Disease indication
5.2 Usage
5.2.1 Introduction
5.2.2 Hospitals
5.2.3 Acute Care Centers
5.2.4 Diagnostic Laboratories
5.2.5 Clinic
5.2.6 Y-o-Y Growth Analysis, By Usage
5.2.7 Market Attractiveness Analysis, By Usage
5.2.8 Market Share Analysis, By Usage
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Disease indication
6.1.3.3 By Usage
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Disease indication
6.1.4.3 By Usage
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Disease indication
6.1.5.3 By Usage
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Beckman Coulters
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Siemens Healthcare Diagnostics
8.3 bioMérieux Inc
8.4 DiaSorin S.p.A
8.5 IBL-America
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
